Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children

• Status: Not yet recruiting
• Trial end date: 2021-11-20
• Target enrollment: 0
• Participant gender: All

Summary

Better management and improving outcome of children with allergic rhinitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zagazig University

Criteria

Inclusion Criteria:

• 1. Children with moderate to severe allergic rhinitis according to Allergic Rhinitis And Its Impact On Asthma (ARIA) guidelines[9], which interfere with daily activity or sleep.

2. Children aged (6-12) years with clinical history of allergic rhinitis for at least one year.

3. Children with allergic rhinitis who failed medical treatment, desire an alternative to pharmacotherapy.

4. Sex : male and female.

Exclusion Criteria:

• 1. Children with chronic lung & heart diseases as: asthma and anatomical malformation for respiratory system.

2. disorders: Gastro Esophageal Reflux Disease, cystic fibrosis and epilepsy. 3.Children with chronic drug use: oral or nasal corticosteroids, antiepileptic and immunosuppressive.